BioSenic S.A.
BIOS.BR · BRU
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | €0 | €0 | €0 | €0 |
| % Growth | -100% | 83.4% | -5.1% | – |
| Cost of Goods Sold | €0 | €0 | €0 | €0 |
| Gross Profit | -€0 | €0 | €0 | €0 |
| % Margin | – | 100% | 100% | 316.3% |
| R&D Expenses | €0 | €0 | €0 | €0 |
| G&A Expenses | €0 | €0 | €0 | €0 |
| SG&A Expenses | €0 | €0 | €0 | €0 |
| Sales & Mktg Exp. | €0 | -€0 | €0 | €0 |
| Other Operating Expenses | €0 | €0 | -€0 | €0 |
| Operating Expenses | €0 | €0 | €0 | €0 |
| Operating Income | -€0 | -€0 | -€0 | -€0 |
| % Margin | – | -1,296.5% | -783.1% | -381.1% |
| Other Income/Exp. Net | €0 | -€0 | -€0 | €0 |
| Pre-Tax Income | -€0 | -€0 | -€0 | -€0 |
| Tax Expense | €0 | -€0 | €0 | €0 |
| Net Income | -€0 | -€0 | -€0 | -€0 |
| % Margin | – | -5,299.8% | -689.5% | -315.4% |
| EPS | -0.021 | -0.21 | -0.017 | -0.046 |
| % Growth | 90.2% | -1,135.3% | 63.2% | – |
| EPS Diluted | -0.021 | -0.21 | -0.017 | -0.046 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | €0 | €0 | €0 |
| Interest Expense | €0 | €0 | €0 | €0 |
| Depreciation & Amortization | €0 | €0 | €0 | €0 |
| EBITDA | -€0 | -€0 | -€0 | -€0 |
| % Margin | – | -1,251.6% | -762.8% | -276.9% |